You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for SODIUM BICARB


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SODIUM BICARB

Average Pharmacy Cost for SODIUM BICARB

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SODIUM BICARBONATE 8.4% VIAL 81665-0200-25 0.16826 ML 2024-12-18
SODIUM BICARB 650 MG TABLET 00536-1047-10 0.01334 EACH 2024-12-18
SODIUM BICARB 650 MG TABLET 00904-7261-61 0.01334 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for SODIUM BICARB

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
SODIUM BICARBONATE 325MG TAB Richmond Pharmaceuticals Inc. 54738-0035-03 1000 8.94 0.00894 EACH 2024-02-15 - 2029-02-14 FSS
SODIUM BICARBONATE 650MG TAB Richmond Pharmaceuticals Inc. 54738-0020-03 1000 10.15 0.01015 EACH 2024-02-15 - 2029-02-14 FSS
SODIUM BICARBONATE 84MG/ML INJ,SYRINGE,50ML Amphastar Pharmaceuticals, Inc. 76329-3352-01 10X50ML 117.49 2022-01-15 - 2027-01-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

SODIUM BICARB Market Analysis and Financial Projection

Market Analysis and Price Projections for Pharmaceutical Grade Sodium Bicarbonate

Market Overview

The global pharmaceutical grade sodium bicarbonate market is poised for significant growth, driven by increasing demand from the pharmaceutical industry. Here are the key points to consider:

Market Size and Growth

The global pharmaceutical grade sodium bicarbonate market is valued at approximately $274.8 million in 2024 and is projected to reach $387.7 million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 3.5% during this period[1][3].

Applications and Drivers

Sodium bicarbonate is widely used in the pharmaceutical industry as an active pharmaceutical ingredient (API) for treating various conditions, including metabolic acidosis, hemodialysis, cardiac arrest, extracorporeal blood circulation, and uncontrolled diabetes. The growing geriatric population is a significant driver, as it increases the demand for sodium-based medications[1].

Market Segmentation

The market is segmented based on grade, with the coarse segment expected to hold a dominant market share of 78.2% in 2024. This segmentation highlights the preference for coarse-grade sodium bicarbonate in pharmaceutical applications[1].

Regional Analysis

The global market is distributed across various regions, with North America, Europe, and Asia-Pacific being key players. Europe holds a significant market share, while the Asia-Pacific region is expected to grow at a CAGR of 7.0% from 2024 to 2031, driven by robust demand in the food and beverage sector as well as pharmaceutical applications[4].

Competitive Landscape

The market is dominated by Tier-I companies that focus on developing high-quality pharma-grade sodium bicarbonate and advanced mining technologies. These companies are investing in robust strategies to enhance customer experience and expand their market reach, particularly through e-commerce channels[1].

Price Trends

Current Prices

As of March 2024, the prices of sodium bicarbonate vary by region:

  • USA: $545 USD/MT
  • Europe: $400 USD/MT
  • Asia: Prices have been fluctuating, with recent values around 2150 RMB/ton to 2688 RMB/ton in the last quarter of 2023[2].

Historical Price Trends

Historically, sodium bicarbonate prices have shown significant fluctuations:

  • In the second half of 2022, prices in the Asia-Pacific region declined due to poor performance of feedstock materials and downstream industries, along with maintenance shutdowns and economic fluctuations[2].
  • In North America, prices fell significantly in 2023 due to declining sales in downstream industries, high inventories, and inflationary pressures[2].

Future Projections

The price trend of sodium bicarbonate is expected to decline in the upcoming quarters due to subdued demand and challenging market conditions. The cost of feedstock materials and the global economic outlook do not support an immediate rise in prices[2].

Market Dynamics

Demand Factors

The demand for pharmaceutical grade sodium bicarbonate is driven by its versatile applications in the pharmaceutical industry. The growing need for treatments of metabolic disorders and the increasing use in hemodialysis are key demand drivers[1].

Supply Factors

The supply side is influenced by the availability of feedstock materials and the production capacities of major manufacturers. Government policies, such as foreign direct investments and infrastructure development programs, also play a crucial role in enhancing supply chain efficiency[1].

Regional Market Insights

North America

North America is a significant market, with the United States being a major consumer. However, the region has seen a decline in prices due to reduced demand from downstream industries and high inventory levels[2][4].

Europe

Europe holds a substantial market share, with a market size of $1455.45 million in 2024. The region is expected to grow at a CAGR of 3.5% from 2024 to 2031[4].

Asia-Pacific

The Asia-Pacific region, particularly China, is a key player due to its large production capacity and robust demand from the food and beverage sector. The region is expected to grow at a CAGR of 7.0% from 2024 to 2031[4].

Key Takeaways

  • The global pharmaceutical grade sodium bicarbonate market is expected to grow at a CAGR of 3.5% from 2024 to 2034.
  • The market is driven by increasing demand from the pharmaceutical industry, particularly for treating metabolic acidosis and other conditions.
  • Regional prices vary significantly, with Asia-Pacific and Europe being key markets.
  • Future price trends are expected to decline due to subdued demand and challenging market conditions.

FAQs

Q: What is the projected market size of the global pharmaceutical grade sodium bicarbonate market by 2034? A: The global pharmaceutical grade sodium bicarbonate market is projected to reach $387.7 million by 2034[1].

Q: What are the primary applications of pharmaceutical grade sodium bicarbonate? A: Pharmaceutical grade sodium bicarbonate is used in treating metabolic acidosis, hemodialysis, cardiac arrest, extracorporeal blood circulation, and uncontrolled diabetes[1].

Q: Which region is expected to grow at the highest CAGR from 2024 to 2031? A: The Asia-Pacific region is expected to grow at a CAGR of 7.0% from 2024 to 2031[4].

Q: What are the factors influencing the price trend of sodium bicarbonate? A: The price trend is influenced by the cost of feedstock materials, global economic outlook, and demand from downstream industries[2].

Q: Who are the key players in the global pharmaceutical grade sodium bicarbonate market? A: The market is dominated by Tier-I companies that focus on developing high-quality pharma-grade sodium bicarbonate and advanced mining technologies[1].

Sources

  1. Future Market Insights: "Rising Usage of Sodium Bicarbonate in Cleansing Solutions and Systemic Alkalizer to Surge Pharma Grade Sodium Bicarbonate Market at 3.5% CAGR by 2034"[1].
  2. Procurement Resource: "Sodium Bicarbonate Price Trend, Database, News, Forecast"[2].
  3. Future Market Insights: "Pharmaceutical Grade Sodium Bicarbonate Market Forecast 2033"[3].
  4. Cognitive Market Research: "Global Sodium Bicarbonate Market Report 2024"[4].
  5. Intratec: "Sodium Bicarbonate Prices | Historical and Current"[5].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.